MiR-144 inhibits colorectal cancer cell migration and invasion by regulating PBX3
B. Cheng, Y. Zhang, Z.-W. Wu, Z.-C. Cui, W.-L. Li Department of Emergency Surgery, the First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. lwldoctor@163.com
OBJECTIVE: MicroRNAs (miRNA) are aberrantly expressed in various human cancers, including colorectal cancer (CRC). We aim to investigate the functional role and underlying mechanism of miR-144 in CRC.
PATIENTS AND METHODS: The expressional level of miR-144 and pre-leukemia transcription factor 3 (PBX3) in CRC tissues and cells was confirmed by quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) and Western blot. The migration and invasion of CRC cells were detected by transwell assay. Luciferase reporter assay was performed to determine the specific target of miR-144 in CRC cells.
RESULTS: The results displayed that miR-144 expression was significantly decreased in CRC tissues and cells compared to that in normal controls. Additionally, miR-144 mimic suppressed, while miR-144 inhibitor promoted the ability of CRC cell migration and invasion. More importantly, PBX3 was the direct target of miR-144 in regulating CRC development and PBX3 could reverse the inhibitory effect of miR-144 mimic on CRC cells. PBX3 expression was significantly increased in CRC and negatively correlated with miR-144 expression.
CONCLUSIONS: In conclusion, miR-144 suppressed CRC cell migration and invasion by targeting PBX3, suggesting its potential value in the diagnosis and treatment of CRC.
Free PDF Download
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
To cite this article
B. Cheng, Y. Zhang, Z.-W. Wu, Z.-C. Cui, W.-L. Li
MiR-144 inhibits colorectal cancer cell migration and invasion by regulating PBX3
Eur Rev Med Pharmacol Sci
Year: 2020
Vol. 24 - N. 18
Pages: 9361-9369
DOI: 10.26355/eurrev_202009_23019